FL
Fifth Lane Capital, LP
13F filer · CIK 0001858558Reported Aug 6, 2026
Net seller this quarter
13F portfolio value$1.63MU.S. long equity reported on 13F
Positions32 new · 50 closed
Net flow last quarter-$75.8MBuys minus sells
Top 10 positions weight84.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 6, 20263 positions | |||||
| $893K | 54.75% | Not reported | -10.6% | Q3 2025 | |
| $257K | 15.77% | 0.08% | New | Q2 2026 | |
| AIASPCASPAC III Acquisition Corp. | $220K | 13.46% | Not reported | New | Q2 2026 |
| Q1 2026Reported May 15, 202651 positions | |||||
| $11.2M | 13.61% | Not reported | +47.8% | Q3 2025 | |
| $7.65M | 9.29% | Not reported | New | Q1 2026 | |
| HHOLXHologic Inc | $7.15M | 8.68% | 0.04% | +190.9% | Q1 2022 |
| $6.47M | 7.85% | Not reported | +48.1% | Q4 2025 | |
| CECEPTCantor Equity Partners II, Inc. | $5.73M | 6.96% | Not reported | +107.7% | Q2 2025 |
| EAEAElectronic Arts Inc. | $3.57M | 4.33% | Not reported | New | Q1 2026 |
| AACLXArcellx, Inc. | $3.56M | 4.33% | 0.05% | New | Q1 2026 |
| FAFCRSFutureCrest Acquisition Corp. | $2.8M | 3.41% | Not reported | +14.8% | Q4 2025 |
| $1.89M | 2.30% | 0.00% | +22.8% | Q2 2025 | |
| $1.77M | 2.14% | 0.02% | +359.7% | Q4 2025 | |
| $1.49M | 1.81% | 0.03% | +132.0% | Q4 2025 | |
| $1.31M | 1.59% | 0.00% | +36.4% | Q4 2024 | |
| $1.27M | 1.54% | Not reported | Not reported | Q3 2025 | |
| $1.17M | 1.43% | 0.03% | +545.5% | Q3 2025 | |
| $863K | 1.05% | 0.06% | Not reported | Q3 2025 | |
| $814K | 0.99% | 0.00% | +33.3% | Q4 2025 | |
| $736K | 0.89% | 0.00% | -16.7% | Q4 2025 | |
| $676K | 0.82% | 0.00% | -33.3% | Q2 2025 | |
| $572K | 0.69% | 0.06% | New | Q1 2026 | |
| $570K | 0.69% | 0.10% | Not reported | Q3 2024 | |
| $558K | 0.68% | 0.00% | -42.3% | Q2 2025 | |
| CGCVGWCalavo Growers Inc | $534K | 0.65% | 0.12% | New | Q1 2026 |
| $529K | 0.64% | 0.00% | New | Q1 2026 | |
| $481K | 0.58% | 0.21% | +490.2% | Q1 2026 | |
| $430K | 0.52% | 0.01% | New | Q1 2026 | |
| TPTERNTerns Pharmaceuticals, Inc. | $422K | 0.51% | 0.01% | New | Q1 2026 |
| $393K | 0.48% | 0.00% | Not reported | Q2 2022 | |
| $383K | 0.47% | Not reported | New | Q1 2026 | |
| $366K | 0.44% | 0.00% | Not reported | Q1 2024 | |
| $349K | 0.42% | Not reported | -40.0% | Q4 2025 | |
| $344K | 0.42% | 0.00% | New | Q1 2026 | |
| $331K | 0.40% | Not reported | New | Q1 2026 | |
| $331K | 0.40% | 0.00% | New | Q1 2026 | |
| $313K | 0.38% | 0.04% | New | Q1 2026 | |
| APAPLSApellis Pharmaceuticals, Inc. | $302K | 0.37% | 0.01% | New | Q1 2026 |
| $298K | 0.36% | Not reported | New | Q1 2026 | |
| $271K | 0.33% | 0.00% | -50.0% | Q4 2024 | |
| $264K | 0.32% | 0.05% | New | Q1 2026 | |
| CPCRNXCrinetics Pharmaceuticals, Inc. | $260K | 0.32% | 0.01% | New | Q1 2026 |
| $225K | 0.27% | 0.00% | Not reported | Q3 2025 | |
| $178K | 0.22% | 0.06% | +210.0% | Q4 2025 | |
| $161K | 0.20% | Not reported | +301.1% | Q4 2025 | |
| $143K | 0.17% | Not reported | New | Q1 2026 | |
| $118K | 0.14% | 0.07% | New | Q1 2026 | |
| $80.4K | 0.10% | 0.00% | New | Q1 2026 | |
| $66.3K | 0.08% | 0.00% | Not reported | Q3 2023 | |
| $58.2K | 0.07% | 0.01% | New | Q1 2026 | |
| $45.2K | 0.05% | 0.00% | -84.5% | Q3 2023 | |
| $41.8K | 0.05% | 0.02% | New | Q1 2026 | |
| $41.4K | 0.05% | 0.08% | New | Q1 2026 | |
| Q4 2025Reported Feb 13, 202667 positions | |||||
| $7.87M | 5.96% | Not reported | -5.6% | Q3 2025 | |
| $4.82M | 3.65% | Not reported | +368.9% | Q3 2025 | |
| $4.43M | 3.36% | Not reported | New | Q4 2025 | |
| ABRNAMAvidity Biosciences, Inc. | $4.4M | 3.33% | 0.04% | New | Q4 2025 |
| $3.69M | 2.79% | Not reported | -14.3% | Q3 2023 | |
| CECEPTCantor Equity Partners II, Inc. | $2.85M | 2.16% | Not reported | -38.5% | Q2 2025 |
| $2.51M | 1.90% | Not reported | New | Q4 2025 | |
| FAFCRSFutureCrest Acquisition Corp. | $2.49M | 1.88% | Not reported | New | Q4 2025 |
| HHOLXHologic Inc | $2.42M | 1.83% | 0.01% | +983.3% | Q1 2022 |
| BDBDCIBTC Development Corp. | $2.28M | 1.73% | Not reported | New | Q4 2025 |
| $1.88M | 1.43% | 0.00% | -16.7% | Q2 2025 | |
| $1.38M | 1.05% | 0.00% | +77.8% | Q2 2025 | |
| CACWANClearwater Analytics Holdings, Inc. | $1.33M | 1.01% | Not reported | New | Q4 2025 |
| $1.29M | 0.97% | 2.07% | New | Q4 2025 | |
| $1.17M | 0.89% | 0.00% | New | Q4 2025 | |
| $1.17M | 0.89% | 0.00% | +160.0% | Q2 2025 | |
| $1.06M | 0.80% | 0.00% | New | Q4 2025 | |
| $1.03M | 0.78% | 0.00% | +10.0% | Q4 2024 | |
| $952K | 0.72% | Not reported | New | Q4 2025 | |
| $946K | 0.72% | Not reported | New | Q4 2025 | |
| $912K | 0.69% | 0.00% | +13.2% | Q2 2025 | |
| $649K | 0.49% | 0.01% | New | Q4 2025 | |
| $642K | 0.49% | 0.00% | New | Q4 2025 | |
| $626K | 0.47% | 0.01% | New | Q4 2025 | |
| TFTHSTreeHouse Foods, Inc. | $590K | 0.45% | 0.05% | New | Q4 2025 |
| $574K | 0.44% | 0.03% | +83.9% | Q3 2023 | |
| $537K | 0.41% | Not reported | New | Q4 2025 | |
| APAVDLAvadel Pharmaceuticals PLC | $521K | 0.39% | 0.02% | New | Q4 2025 |
| $520K | 0.39% | 0.00% | New | Q4 2025 | |
| $473K | 0.36% | 0.18% | New | Q4 2025 | |
| $467K | 0.35% | 0.00% | New | Q4 2025 | |
| $465K | 0.35% | 0.00% | New | Q4 2025 | |
| $444K | 0.34% | 0.00% | Not reported | Q1 2024 | |
| $432K | 0.33% | 0.01% | -63.5% | Q3 2025 | |
| $426K | 0.32% | Not reported | +3.7% | Q3 2025 | |
| $421K | 0.32% | 0.01% | New | Q4 2025 | |
| $419K | 0.32% | 0.00% | +8.7% | Q2 2022 | |
| SASEESealed Air Corp | $414K | 0.31% | 0.01% | New | Q4 2025 |
| $387K | 0.29% | 0.00% | New | Q4 2025 | |
| $375K | 0.28% | Not reported | New | Q4 2025 | |
| $359K | 0.27% | Not reported | New | Q4 2025 | |
| RARAAQReal Asset Acquisition Corp. | $357K | 0.27% | Not reported | New | Q4 2025 |
| $353K | 0.27% | Not reported | +16.3% | Q3 2025 | |
| $348K | 0.26% | 0.00% | New | Q4 2025 | |
| $348K | 0.26% | 0.00% | Not reported | Q4 2024 | |
| $324K | 0.25% | 0.05% | +37.2% | Q3 2025 | |
| $281K | 0.21% | 0.01% | New | Q4 2025 | |
| $274K | 0.21% | 0.00% | New | Q4 2025 | |
| $274K | 0.21% | 0.24% | +427.3% | Q4 2024 | |
| $249K | 0.19% | 0.01% | New | Q4 2025 | |
| Q3 2025Reported Nov 12, 202595 positions | |||||
| $8.52M | 8.56% | Not reported | New | Q3 2025 | |
| $4.84M | 4.86% | Not reported | New | Q3 2025 | |
| CECEPTCantor Equity Partners II, Inc. | $4.35M | 4.37% | Not reported | -31.2% | Q2 2025 |
| $4.2M | 4.22% | Not reported | Not reported | Q3 2023 | |
| $3.43M | 3.44% | Not reported | New | Q3 2025 | |
| CECAEPCantor Equity Partners III, Inc. | $3.24M | 3.25% | Not reported | +25.4% | Q2 2025 |
| VAVLOSVelos Acquisition I Corp. | $2.95M | 2.96% | Not reported | -15.2% | Q2 2025 |
| $2.69M | 2.71% | Not reported | New | Q3 2025 | |
| CCCCCMColumbus Circle Capital Corp I | $2.55M | 2.56% | Not reported | New | Q3 2025 |
| BDBDCIUBTC Development Corp. | $2.53M | 2.54% | Not reported | New | Q3 2025 |
| $2.36M | 2.37% | 0.00% | +356.2% | Q2 2025 | |
| $1.95M | 1.96% | Not reported | -4.7% | Q2 2025 | |
| $1.82M | 1.83% | Not reported | -11.5% | Q2 2025 | |
| $1.56M | 1.57% | 2.00% | -25.0% | Q2 2025 | |
| $1.2M | 1.20% | 0.00% | Not reported | Q3 2023 | |
| $1.15M | 1.15% | Not reported | -53.9% | Q2 2025 | |
| $1.04M | 1.04% | 0.00% | New | Q3 2025 | |
| TABLZRUTrailblazer Acquisition Corp. | $1.03M | 1.03% | Not reported | New | Q3 2025 |
| $1.02M | 1.02% | Not reported | New | Q3 2025 | |
| $975K | 0.98% | 0.00% | Not reported | Q4 2024 | |
| $933K | 0.94% | 0.00% | -37.5% | Q4 2024 | |
| $932K | 0.94% | 0.04% | New | Q3 2025 | |
| $813K | 0.82% | Not reported | New | Q3 2025 | |
| $742K | 0.75% | 0.00% | -25.0% | Q2 2025 | |
| $740K | 0.74% | 0.00% | +6.0% | Q2 2025 | |
| $717K | 0.72% | 0.16% | New | Q3 2025 | |
| CCCCRNCross Country Healthcare Inc | $711K | 0.71% | 0.15% | New | Q3 2025 |
| CIGTLSChart Industries Inc | $653K | 0.66% | 0.01% | New | Q3 2025 |
| $607K | 0.61% | Not reported | New | Q3 2025 | |
| $599K | 0.60% | 0.00% | +47.1% | Q1 2025 | |
| $542K | 0.54% | 0.03% | New | Q3 2025 | |
| 1AONCHU1RT Acquisition Corp. | $525K | 0.53% | Not reported | New | Q3 2025 |
| $516K | 0.52% | 0.00% | -75.8% | Q2 2022 | |
| IAIASIntegral Ad Science Holding Corp. | $509K | 0.51% | 0.03% | New | Q3 2025 |
| $485K | 0.49% | Not reported | New | Q3 2025 | |
| $476K | 0.48% | 0.00% | New | Q3 2025 | |
| $476K | 0.48% | Not reported | -12.5% | Q2 2025 | |
| $451K | 0.45% | 0.00% | New | Q3 2025 | |
| $451K | 0.45% | Not reported | New | Q3 2025 | |
| $445K | 0.45% | 0.00% | -33.3% | Q2 2025 | |
| $445K | 0.45% | 0.30% | +20.0% | Q2 2025 | |
| STSLNOSoleno Therapeutics Inc | $443K | 0.44% | 0.01% | New | Q3 2025 |
| $441K | 0.44% | Not reported | Not reported | Q2 2025 | |
| $440K | 0.44% | 0.01% | -11.1% | Q3 2024 | |
| MMTSRMetsera, Inc. | $436K | 0.44% | 0.01% | New | Q3 2025 |
| $419K | 0.42% | 0.02% | +169.2% | Q3 2023 | |
| SISBXDSilverBox Corp IV | $402K | 0.40% | Not reported | -68.0% | Q2 2025 |
| $392K | 0.39% | Not reported | New | Q3 2025 | |
| $350K | 0.35% | 0.00% | New | Q3 2025 | |
| $323K | 0.32% | 0.21% | New | Q3 2025 | |
Premium opens every quarter this fund has filed